Binimetinib,Ipatasertib,Nilotinib,Olaparib,Palbociclib,Panitumumab,Selumetinib,Sotorasib
Pfizer,Roche,Novartis,inhibikase,Merck,Amgen,Astrazeneca
['biomarker', 'selection,(-selectionlte),(-selection lte),(-selection-lte)', 'match trial']
 exciting results from the #combomatch trial by ! 1 precision medicine approach led to higher rr &amp; longer pfs 2 combining targeted therapies showed promise in treating advanced cancers 3 identifies potential biomarkers therapy selection 
Leader GU @InstitutoRoffo #GU #RCC #prostate #bladder #testis #GUcsm #clinicaltrials #Immunotherapy #PrecisionMedicine #OncoAlert #OncoReporte
Views Mine